Efficacy of a Chronic Care Model Supported by Self Monitoring of Blood Glucose With BGStar Over Usual Care in Improving Glycemic Control in Patients With Type 2 Diabetes Not Treated With Insulin

NACompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

June 27, 2012

Primary Completion Date

July 30, 2015

Study Completion Date

July 30, 2015

Conditions
Diabetes Mellitus
Interventions
DEVICE

BGStar

DEVICE

glucose meter

Trial Locations (20)

24128

Investigational Site Number 006, Bergamo

47900

Investigational Site Number 012, Rimini

95122

Investigational Site Number 022, Catania

Unknown

Investigational Site Number 016, Andria (BA)

Investigational Site Number 011, Avezzano

Investigational Site Number 002, Brescia

Investigational Site Number 001, Cusano Milanino

Investigational Site Number 013, Livorno

Investigational Site Number 015, Lucca

Investigational Site Number 004, Mariano Comense

Investigational Site Number 017, Messina

Investigational Site Number 008, Milan

Investigational Site Number 018, Napoli

Investigational Site Number 021, Potenza

Investigational Site Number 020, Ragusa

Investigational Site Number 014, Ravenna

Investigational Site Number 009, Roma

Investigational Site Number 019, Terlizzi (BA)

Investigational Site Number 007, Torino

Investigational Site Number 003, Udine

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY